Tyrosine Kinase Expressed in Hepatocellular Carcinoma, TEC, Controls Pluripotency and Early Cell Fate Decisions of Human Pluripotent Stem Cells via Regulation of Fibroblast Growth Factor-2 Secretion
Language English Country Great Britain, England Media print-electronic
Document type Journal Article
PubMed
28631381
DOI
10.1002/stem.2660
Knihovny.cz E-resources
- Keywords
- Cardiac differentiation, Embryonic stem cells, Fibroblast growth factor, Fibroblast growth factor 2, Neural differentiation, Pluripotent stem cells, Tyrosine kinase expressed in hepatocellular carcinoma,
- MeSH
- Biomarkers metabolism MeSH
- Cell Line MeSH
- Cell Lineage * drug effects MeSH
- Down-Regulation drug effects MeSH
- Fibroblast Growth Factor 2 metabolism MeSH
- Humans MeSH
- Pluripotent Stem Cells cytology enzymology MeSH
- Cell Proliferation drug effects MeSH
- Recombinant Proteins pharmacology MeSH
- Protein-Tyrosine Kinases metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Biomarkers MeSH
- Fibroblast Growth Factor 2 MeSH
- Recombinant Proteins MeSH
- Tec protein-tyrosine kinase MeSH Browser
- Protein-Tyrosine Kinases MeSH
Human pluripotent stem cells (hPSC) require signaling provided by fibroblast growth factor (FGF) receptors. This can be initiated by the recombinant FGF2 ligand supplied exogenously, but hPSC further support their niche by secretion of endogenous FGF2. In this study, we describe a role of tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase in this process. We show that TEC-mediated FGF2 secretion is essential for hPSC self-renewal, and its lack mediates specific differentiation. Following both short hairpin RNA- and small interfering RNA-mediated TEC knockdown, hPSC secretes less FGF2. This impairs hPSC proliferation that can be rescued by increasing amounts of recombinant FGF2. TEC downregulation further leads to a lower expression of the pluripotency markers, an improved priming towards neuroectodermal lineage, and a failure to develop cardiac mesoderm. Our data thus demonstrate that TEC is yet another regulator of FGF2-mediated hPSC pluripotency and differentiation. Stem Cells 2017;35:2050-2059.
Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic
Heidelberg University Biochemistry Center Heidelberg Germany
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
References provided by Crossref.org